Sign in
Active, not recruitingNo phase

Myopia Control Efficacy of Second-generation DIMS Spectacle Lenses on Fast Progressing Myopes - Auxiliary Group

Key facts

Who runs it
The Hong Kong Polytechnic University
Where
Hong Kong1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
59 people, planned
Started
29 Jul 2023
Expected to end
31 Dec 2028
Type of study
Interventional
Treatments tested
  • DIMS spectacle lens
Record updated
22 April 2026

Who can take part

Age
4 years to 12 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • SER: -1.00D or below
  • Documented history of fast progressing myopia, either in SER or AL
  • SER progression: 0.50D/year or more
  • AL elongation: 0.27mm/year or more
  • Best-corrected monocular visual acuity (VA) in both eyes: 0.00 logMAR (equivalent) or better
  • Acceptance of random group allocation and the masked study design
  • Anisometropia of 1.50 D or less
  • Astigmatism of 2.00 D or less

Who cannot take part

  • Prior experience of myopia control
  • Strabismus and binocular vision abnormalities
  • Ocular and systemic abnormalities

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to examine the efficacy and performance of the Defocus Incorporated Multiple Segments (DIMS) and a variant of DIMS (D2) spectacle lenses on controlling myopia progression in fast progressing myopic children.

The group in the trial

  • DIMS to D2 lens groupOther group

    Participants will be prescribed with a pair of DIMS spectacle lenses for 24 months. They will then wear a pair of D2 spectacle lenses for an additional 24 months.

    Treatment: DIMS spectacle lens

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
22 April 2026